Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide for irritable bowel syndrome
NL-OMON28758Suspended
- Start
- Apr 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Trial of budesonide in irritable bowel syndrome (IBS) (2 arms). Primary endpoint: Effect of budesonide on rectal sensitivity. Started Apr 2005; status: suspended.
02
Drugs
budesonide
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NL-OMON28758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28758.